NRGene Announces Expanded Licensing Agreement with Bayer for the GenoMAGIC Platform
Following successful evaluation, Bayer has chosen the GenoMAGICTM platform to support its advanced molecular breeding program in several key crops Ness Ziona, Israel – (December 3, 2018) –NRGene, the worldwide leader in genomic analysis, announces a key milestone in its multi-year licensing agreement with Bayer for the use of GenoMAGICTM, a cloud-based big data analytics platform... Read more